REG - Morgan Stanley Cap - Rule 38.5 - ABBVIE INC.

Morgan StanleyAnnouncement

19/03/2020 11:45

RNS Number : 7934G
  
Morgan Stanley Capital Services LLC
  
19 March 2020
  
 

 
 FORM 38.5 
 
IRISH TAKEOVER PANEL
 
DISCLOSURE UNDER RULE 38.5 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER  RULES, 2007 (AS AMENDED)
 
DEALINGS BY CONNECTED EXEMPT MARKET-MAKERS
 
1.             KEY INFORMATION



 Name of exempt market-maker


   Morgan Stanley Capital Services LLC




 Company dealt in


   ABBVIE INC.




 Class of relevant security to which the dealings being disclosed relate (Note 1)


  US$0.01 COMMON STOCK




 Date of dealing


   18 MARCH 2020



 
 
2.             DEALINGS (Note 2)
 
(a)           Purchases and sales



 Total number of relevant secuities accquired


 Highest price paid (Note 3)


 Lowest price paid (Note 3)




  296,837


 71.0800 USD


 64.7200 USD



 



 Total number of relevant secuities disposed


 Highest price paid (Note 3)


 Lowest price paid (Note 3)




  49,783


 71.0300 USD


 64.7200 USD



 
 
(b)           Derivatives transactions (other than options transactions)
 



 Product name, e.g. CFD


 Nature of transaction 
                (Note 4)


 Number of relevant securities 
                (Note 5)


 Price per unit




 CFD


 LONG


 4,185


 65.1385 USD




 CFD


 LONG


 4,330


 66.1065 USD




 CFD


 LONG


 230


 66.5291 USD




 CFD


 LONG


 3,000


 66.9104 USD




 CFD


 LONG


 700


 66.9104 USD




 CFD


 LONG


 1,500


 66.9104 USD




 CFD


 LONG


 80


 67.4162 USD




 CFD


 LONG


 119


 68.8382 USD




 CFD


 LONG


 990


 68.8382 USD




 CFD


 LONG


 3,100


 69.8396 USD




 CFD


 LONG


 11,258


 70.4149 USD




 CFD


 LONG


 715


 71.0300 USD




 CFD


 LONG


 10,585


 71.0300 USD




 CFD


 SHORT


 36,757


 65.6116 USD




 CFD


 SHORT


 5,629


 66.2416 USD




 CFD


 SHORT


 13,685


 67.0266 USD




 CFD


 SHORT


 5,800


 67.0509 USD




 CFD


 SHORT


 800


 67.0509 USD




 CFD


 SHORT


 600


 67.0509 USD




 CFD


 SHORT


 200


 67.1300 USD




 CFD


 SHORT


 22,195


 67.1346 USD




 CFD


 SHORT


 10


 67.2100 USD




 CFD


 SHORT


 1,992


 67.4765 USD




 CFD


 SHORT


 1,382


 68.2465 USD




 CFD


 SHORT


 1,370


 68.2465 USD




 CFD


 SHORT


 520


 68.6444 USD




 CFD


 SHORT


 15,855


 68.9682 USD




 CFD


 SHORT


 1,465


 68.9682 USD




 CFD


 SHORT


 14,400


 69.3149 USD




 CFD


 SHORT


 2,858


 70.0339 USD




 CFD


 SHORT


 897


 70.4305 USD




 CFD


 SHORT


 104


 71.0300 USD




 CFD


 SHORT


 124,265


 71.0300 USD




 CFD


 SHORT


 41,116


 71.0300 USD



 
 
(c)            Options transactions in respect of existing relevant securities
 
i)           Writing, selling, purchasing or varying
 



 Product name, eg call option


 Writing, selling, purchasing, varying etc


 Number of securities to which the option relates (Note 5)


 Exercise Price


 Type, e.g American, European etc 


 Expiry Date 


 Option money paid/received per unit (Note 3)




 N/A


 N/A


 N/A


 N/A


 N/A


 N/A


 N/A 



 
(ii) Exercising
 



 Product name, eg call option


 Number of securities


 Exercise price per unit (Note 3)




 N/A


 N/A


 N/A  



 
 
3. OTHER INFORMATION
 
Agreements, arrangements or understandings relating to options or derivatives
 



Full Details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
 




 
 
 
 
 



 
 



 Date of disclosure


 19 MARCH 2020




 Contact Name


Craig Horsley




 Telephone Number


+44(141) 245 7736 




 Name of offeree/offeror with which connected


ABBVIE INC. 




Nature of connection (Note 6)


Advisory 



 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
ISEUKSRRRSUOAAR